- Phase III Trial of Consolidation Therapy With Yttrium-90-Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma
[作者:Morschhauser, F; Radford, J; Van Hoof, A; Vitolo, U; Soubeyran, P; Tilly, H; Huijgens, PC; Kolstad, A; d'Amore, F; Diaz, MG; Petrini, M; Sebban, C; Zinzani, PL; van Oers, MHJ; van Putten, W; Bischof-Delaloye, A; Rohatiner, A; Salles, G; Kuhlmann, J; Hagenbeek, A,期刊:Journal of clinical oncology, 页码:5156-5164 , 文章类型: Article,,卷期:2008年26-32]
- PurposeWe conducted an international, randomized, phase III trial to evaluate the efficacy and safety of consolidation with yttrium-90 (Y-90)-ibritumomab tiuxetan in patients with advanced-stage follicular lymphoma in fi...
- Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Patient Perceptions and Precautionary Behaviors
[作者:McLaughlin, SA; Wright, MJ; Morris, KT; Sampson, MR; Brockway, JP; Hurley, KE; Riedel, ER; Van Zee, KJ,期刊:Journal of clinical oncology, 页码:5220-5226 , 文章类型: Article,,卷期:2008年26-32]
- PurposeSentinel lymph node (SLN) biopsy was adopted for the staging of the axilla with the assumption that it would reduce the risk of lymphedema in women with breast cancer. This study was undertaken to examine patient ...
- Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma
[作者:Al-Tourah, AJ; Gill, KK; Chhanabhai, M; Hoskins, PJ; Klasa, RJ; Savage, KJ; Sehn, LH; Shenkier, TN; Gascoyne, RD; Connors, JM,期刊:Journal of clinical oncology, 页码:5165-5169 , 文章类型: Article,,卷期:2008年26-32]
- Purpose To assess the incidence and predictive factors for development of transformed lymphoma in a population-based series of patients with follicular lymphoma (FL).Patients and MethodsThe Lymphoid Cancer Database was u...
- Involved-Nodal Radiation Therapy As a Component of Combination Therapy for Limited-Stage Hodgkin's Lymphoma: A Question of Field Size
[作者:Campbell, BA; Voss, N; Pickles, T; Morris, J; Gascoyne, RD; Savage, KJ; Connors, JM,期刊:Journal of clinical oncology, 页码:5170-5174 , 文章类型: Article,,卷期:2008年26-32]
- PurposeCombined-modality therapy is the standard of care for limited-stage Hodgkin's lymphoma (HL). Radiation therapy has evolved from extended-field radiation therapy (EFRT) to involved-field radiation therapy (IFRT), r...
- Tamoxifen Use and Osteoporotic Fracture Risk: A Population-Based Analysis
[作者:Cooke, AL; Metge, C; Lix, L; Prior, HJ; Leslie, WD,期刊:Journal of clinical oncology, 页码:5227-5232 , 文章类型: Article,,卷期:2008年26-32]
- PurposeAlthough tamoxifen has been shown to increase bone mineral density in clinical trials, it is less clear whether this significantly affects fracture rates. Even fewer data are available on skeletal outcomes when ta...
- High-Dose Yttrium-90-Ibritumomab Tiuxetan With Tandem Stem-Cell Reinfusion: An Outpatient Preparative Regimen for Autologous Hematopoietic Cell Transplantation
[作者:Devizzi, L; Guidetti, A; Tarella, C; Magni, M; Matteucci, P; Seregni, E; Chiesa, C; Bombardieri, E; Di Nicola, M; Carlo-Stella, C; Gianni, AM,期刊:Journal of clinical oncology, 页码:5175-5182 , 文章类型: Article,,卷期:2008年26-32]
- PurposeTo develop high-dose myeloablative therapy for CD20(+) non-Hodgkin's lymphoma (NHL) as a safe and widely applicable regimen.Patients and MethodsPatients with relapsed/refractory (n = 25) or de novo high-risk (n = ...
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
[作者:Dudley, ME; Yang, JC; Sherry, R; Hughes, MS; Royal, R; Kammula, U; Robbins, PF; Huang, J; Citrin, DE; Leitman, SF; Wunderlich, J; Restifo, NP; Thomasian, A; Downey, SG; Smith, FO; Klapper, J; Morton, K; Laurencot, C; White, DE; Rosenberg, SA,期刊:Journal of clinical oncology, 页码:5233-5239 , 文章类型: Article,,卷期:2008年26-32]
- PurposeThe two approved treatments for patients with metastatic melanoma, interleukin (IL)-2 and dacarbazine, mediate objective response rates of 12% to 15%. We previously reported that adoptive cell therapy (ACT) with a...
- Matched Unrelated or Matched Sibling Donors Result in Comparable Survival After Allogeneic Stem-Cell Transplantation in Elderly Patients With Acute Myeloid Leukemia: A Report From the Cooperative German Transplant Study Group
[作者:Schetelig, J; Bornhauser, M; Schmid, C; Hertenstein, B; Schwerdtfeger, R; Martin, H; Stelljes, M; Hegenbart, U; Schafer-Eckart, K; Fussel, M; Wiedemann, B; Thiede, C; Kienast, J; Baurmann, H; Ganser, A; Kolb, HJ; Ehninger, G,期刊:Journal of clinical oncology, 页码:5183-5191 , 文章类型: Article,,卷期:2008年26-32]
- PurposeIn patients with acute myeloid leukemia (AML), differential indications for matched sibling and unrelated hematopoietic stem-cell transplantation (HCT) are considered, and arbitrary age limits for HCT exist. We so...
- Long-Term Effects of High-Dose Chemotherapy and Radiation for Relapsed and Refractory Hodgkin's Lymphoma
[作者:Goodman, KA; Riedel, E; Serrano, V; Gulati, S; Moskowitz, CH; Yahalom, J,期刊:Journal of clinical oncology, 页码:5240-5247 , 文章类型: Article,,卷期:2008年26-32]
- PurposeTo evaluate the risk of late morbidity and mortality, and to assess long-term health-related quality of life (QOL) among patients with relapsed/refractory Hodgkin's lymphoma (HL) after high-dose chemoradiotherapy ...
- Phase III, Double-Blind Study of Depot Octreotide Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy: Results of North Central Cancer Treatment Group N00CA
[作者:Martenson, JA; Halyard, MY; Sloan, JA; Proulx, GM; Miller, RC; Deming, RL; Dick, SJ; Johnson, HA; Tai, THP; Zhu, AW; Keit, J; Stien, KJ; Atherton, PJ,期刊:Journal of clinical oncology, 页码:5248-5253 , 文章类型: Article,,卷期:2008年26-32]
- PurposeTo assess the effectiveness of depot octreotide for the prevention of diarrhea during pelvic radiation therapy.Patients and MethodsPatients receiving pelvic radiation therapy (planned minimum dose, 45 Gy; 1.7 to 2...
- Long-Term Disease-Free Survival After Gemtuzumab, Intermediate-Dose Cytarabine, and Mitoxantrone in Patients With CD33(+) Primary Resistant or Relapsed Acute Myeloid Leukemia
[作者:Chevallier, P; Delaunay, J; Turlure, P; Pigneux, A; Hunault, M; Garand, R; Guillaume, T; Avet-Loiseau, H; Dmytruk, N; Girault, S; Milpied, N; Ifrah, N; Mohty, M; Harousseau, JL,期刊:Journal of clinical oncology, 页码:5192-5197 , 文章类型: Article,,卷期:2008年26-32]
- PurposeTo determine the antitumor activity and safety of a combination of gemtuzumab ozogamicin (GO), intermediate-dose cytarabine, and mitoxantrone (MIDAM) in patients with refractory or relapsed CD33(+) acute myeloid l...
- Preoperative Bevacizumab Does Not Significantly Increase Postoperative Complication Rates in Patients Undergoing Hepatic Surgery for Colorectal Cancer Liver Metastases
[作者:Kesmodel, SB; Ellis, LM; Lin, E; Chang, GJ; Abdalla, EK; Kopetz, S; Vauthey, JN; Rodriguez-Bigas, MA; Curley, SA; Feig, BW,期刊:Journal of clinical oncology, 页码:5254-5260 , 文章类型: Article,,卷期:2008年26-32]
- PurposeAlthough bevacizumab (BV) increases survival rates when used with chemotherapy (CTX) in patients who have metastatic colorectal cancer (CRC), an increase in wound complications has been observed in patients who un...
- Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin
[作者:Tolcher, AW; Mita, A; Lewis, LD; Garrett, CR; Till, E; Daud, AI; Patnaik, A; Papadopoulos, K; Takimoto, C; Bartels, P; Keating, A; Antonia, S,期刊:Journal of clinical oncology, 页码:5198-5203 , 文章类型: Article,,卷期:2008年26-32]
- PurposeTo determine the maximum-tolerated dose (MTD) and assess the safety, pharmacokinetics, and preliminary evidence of antitumor activity of YM155, a small-molecule inhibitor of survivin.Patients and MethodsPatients w...
- Prospective Randomized Study Comparing Docetaxel, Estramustine, and Prednisone With Docetaxel and Prednisone in Metastatic Hormone-Refractory Prostate Cancer
[作者:Machiels, JP; Mazzeo, F; Clausse, M; Filleul, B; Marcelis, L; Honhon, B; D'Hondt, L; Dopchie, C; Verschaeve, V; Duck, L; Verhoeven, D; Jousten, P; Bonny, MA; Moxhon, AM; Tombal, B; Kerger, J,期刊:Journal of clinical oncology, 页码:5261-5268 , 文章类型: Article,,卷期:2008年26-32]
- PurposeTo assess the efficacy and toxicity of the addition of estramustine to docetaxel (D) for the treatment of metastatic hormone-refractory prostate cancer.Patients and MethodsOne hundred fifty patients were randomly ...
- Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study
[作者:Penel, N; Bui, BN; Bay, JO; Cupissol, D; Ray-Coquard, I; Piperno-Neumann, S; Kerbrat, P; Fournier, C; Taieb, S; Jimenez, M; Isambert, N; Peyrade, F; Chevreau, C; Bompas, E; Brain, EGC; Blay, JY,期刊:Journal of clinical oncology, 页码:5269-5274 , 文章类型: Article,,卷期:2008年26-32]
- PurposeThe objective of this phase II trial was to assess the efficacy and toxicity of weekly paclitaxel for patients with metastatic or unresectable angiosarcoma.Patients and MethodsThirty patients were entered onto the...
|